10-51718953-A-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006258.4(PRKG1):​c.593-85632A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.581 in 151,974 control chromosomes in the GnomAD database, including 26,324 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.58 ( 26324 hom., cov: 32)

Consequence

PRKG1
NM_006258.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.83

Publications

4 publications found
Variant links:
Genes affected
PRKG1 (HGNC:9414): (protein kinase cGMP-dependent 1) Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]
PRKG1 Gene-Disease associations (from GenCC):
  • aortic aneurysm, familial thoracic 8
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.653 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006258.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKG1
NM_006258.4
MANE Select
c.593-85632A>C
intron
N/ANP_006249.1
PRKG1
NM_001098512.3
c.548-85632A>C
intron
N/ANP_001091982.1
PRKG1
NM_001374782.1
c.593-85632A>C
intron
N/ANP_001361711.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKG1
ENST00000373980.11
TSL:1 MANE Select
c.593-85632A>C
intron
N/AENSP00000363092.5
PRKG1
ENST00000401604.8
TSL:5
c.548-85632A>C
intron
N/AENSP00000384200.4
PRKG1
ENST00000645324.1
c.593-85632A>C
intron
N/AENSP00000494124.1

Frequencies

GnomAD3 genomes
AF:
0.581
AC:
88296
AN:
151854
Hom.:
26296
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.660
Gnomad AMI
AF:
0.513
Gnomad AMR
AF:
0.438
Gnomad ASJ
AF:
0.661
Gnomad EAS
AF:
0.270
Gnomad SAS
AF:
0.485
Gnomad FIN
AF:
0.579
Gnomad MID
AF:
0.652
Gnomad NFE
AF:
0.594
Gnomad OTH
AF:
0.567
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.581
AC:
88369
AN:
151974
Hom.:
26324
Cov.:
32
AF XY:
0.577
AC XY:
42842
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.660
AC:
27357
AN:
41468
American (AMR)
AF:
0.438
AC:
6682
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.661
AC:
2294
AN:
3470
East Asian (EAS)
AF:
0.270
AC:
1390
AN:
5146
South Asian (SAS)
AF:
0.486
AC:
2340
AN:
4818
European-Finnish (FIN)
AF:
0.579
AC:
6100
AN:
10542
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.594
AC:
40365
AN:
67954
Other (OTH)
AF:
0.561
AC:
1181
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1810
3620
5431
7241
9051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.589
Hom.:
101375
Bravo
AF:
0.575
Asia WGS
AF:
0.422
AC:
1473
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.70
DANN
Benign
0.55
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4400745; hg19: chr10-53478713; API